Modeling SARS-CoV-2 and influenza infections and antiviral treatments in human lung epithelial tissue equivalents

Mostrar otras versiones (1)

There is a critical need for physiologically relevant, robust, and ready-to-use in vitro cellular assay platforms to rapidly model the infectivity of emerging viruses and develop new antiviral treatments. Here we describe the cellular complexity of human alveolar and tracheobronchial air liquid inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Zarkoob, Hoda, Allué-Guardia, Anna, Chen, Yu-Chi, Garcia-Vilanova, Andreu, Jung, Olive, Coon, Steven, Song, Min Jae, Park, Jun-Gyu, Oladunni, Fatai, Miller, Jesse, Tung, Yen-Ting, Kosik, Ivan, Schultz, David, Iben, James, Li, Tianwei, Fu, Jiaqi, Porter, Forbes D., Yewdell, Jonathan, Martinez-Sobrido, Luis, Cherry, Sara, Torrelles, Jordi B., Ferrer, Marc, Lee, Emily M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373898/
https://www.ncbi.nlm.nih.gov/pubmed/35962146
http://dx.doi.org/10.1038/s42003-022-03753-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373898/
https://www.ncbi.nlm.nih.gov/pubmed/35962146
http://dx.doi.org/10.1038/s42003-022-03753-7

Ejemplares similares